ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Wednesday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14. The stock has a fifty day moving average of $0.01. The company has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.